InVivo Therapeutics News - NVIV

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
InVivo Therapeutics Holdings Corporation NVIV NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0474 -7.10% 0.62 0.6684 0.601 0.66 0.6674 20:00:00
more quote information »

Recent News

Date Time Source Heading
8/13/201908:02EDGARQuarterly Report (10-q)
7/19/201916:30EDGARCurrent Report Filing (8-k)
7/16/201908:00BWInVivo Therapeutics Announces Publication of CONTEMPO..
7/12/201908:12EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/12/201908:06EDGARCurrent Report Filing (8-k)
7/12/201908:00BWInVivo Therapeutics Announces Postponement of Annual Meeting
7/05/201908:01EDGARCurrent Report Filing (8-k)
7/01/201906:00EDGARNotice of Effectiveness (effect)
6/21/201916:08EDGARStatement of Changes in Beneficial Ownership (4)
6/21/201908:02EDGARPost-effective Amendment to Registration Statement (pos Am)
6/14/201913:21BWInVivo Therapeutics gibt Vertagung der Hauptversammlung..
6/14/201908:06EDGARCurrent Report Filing (8-k)
6/14/201908:00BWInVivo Therapeutics Announces Adjournment of Annual Meeting
6/14/201907:51EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
6/05/201908:10EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
6/05/201908:07EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/30/201906:01EDGARNotice of Effectiveness (effect)
5/29/201908:00BWInVivo Therapeutics Announces Enrollment of First Two..
5/22/201917:56EDGARStatement of Changes in Beneficial Ownership (4)
5/17/201916:37EDGARPost-effective Amendment to Registration Statement (pos Am)
5/10/201908:03EDGARQuarterly Report (10-q)
4/25/201917:22EDGARProxy Statement (definitive) (def 14a)
4/17/201908:00BWInVivo Therapeutics Announces Presentation of Twelve-Month..
4/15/201917:14EDGARProxy Statement - Notice of Shareholders Meeting..
4/01/201908:15BWInVivo Therapeutics Reports 2018 Year-end Financial Results..
4/01/201908:10EDGARSecurities Registration: Employee Benefit Plan (s-8)
4/01/201908:04EDGARAnnual Report (10-k)
3/20/201918:31EDGARStatement of Changes in Beneficial Ownership (4)
2/20/201916:13EDGARStatement of Changes in Beneficial Ownership (4)
2/14/201913:48EDGARAmended Statement of Ownership (sc 13g/a)
2/14/201913:46EDGARAmended Statement of Ownership (sc 13g/a)
1/16/201916:43EDGARStatement of Changes in Beneficial Ownership (4)
1/16/201916:41EDGARInitial Statement of Beneficial Ownership (3)
1/14/201917:31EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
1/14/201917:26EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
1/14/201917:23EDGARCurrent Report Filing (8-k)
1/14/201908:00BWInVivo Therapeutics Announces Appointment of Richard..
1/04/201916:48EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
1/04/201916:42EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
1/04/201916:40EDGARCurrent Report Filing (8-k)
1/04/201916:06EDGARAmended Statement of Ownership (sc 13g/a)
12/20/201815:05EDGARStatement of Changes in Beneficial Ownership (4)
12/14/201809:06EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
12/14/201808:55EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
12/14/201808:49EDGARCurrent Report Filing (8-k)
11/29/201808:00BWInVivo Therapeutics to Present at the LD Micro Main Event on..
11/16/201817:09EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
11/16/201817:00EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
11/16/201816:47EDGARCurrent Report Filing (8-k)
11/13/201808:16EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
See more news about this stock »

Your Recent History
InVivo The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.